[PDF] Top 20 Afectación periodontal en el paciente con Síndrome de Sjögren primario
Has 10000 "Afectación periodontal en el paciente con Síndrome de Sjögren primario" found on our website. Below are the top 20 most common "Afectación periodontal en el paciente con Síndrome de Sjögren primario".
Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPD
... tion, patients had to be willing and able, in the opinion of the Investigator, to change current COPD ...Female patients must have agreed to take acceptable con‑ traceptive precautions during the ... See full document
5
Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD
... of formoterol, that is, the AUC 0–12 and C max ratios for all three doses of BFF MDI versus FF MDI ...of formoterol in the fixed-dose combination BFF MDI did not markedly alter the systemic ... See full document
16
Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial
... with moderate to very severe COPD conducted in 131 centers located in South America, Asia, Africa, Europe, and North ...combination. Patients were randomly assigned for 26 weeks (the treatment ... See full document
9
<p>Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD</p>
... and safety of GFF MDI in patients with moder- ate-to-very severe chronic obstructive pulmonary disease (COPD) from Asia, Europe, and the ...(NCT02343458), patients received GFF MDI ... See full document
12
<p>Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD</p>
... Japanese patients reported low use of rescue medication, ranging from ...of patients experiencing a moderate or severe COPD exacerbation over 52 weeks ranged from ...of moderate ... See full document
7
<p>Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study</p>
... symptoms compared with LAMA/LABA (GFF MDI) and ICS/LABA (BFF MDI) combination ...of moderate or severe COPD exacerbations ...Japanese patients with COPD despite the fact that ... See full document
6
Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD
... the addition of, or treatment with, oral or systemic corti- costeroids) occurred within 3 months of randomization to the ICS/LABA combination in COPD patients who had experienced at least one exacerbation ... See full document
50
Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study
... other COPD clinical trials; a meta-analysis of long-acting bronchodilator COPD trials showed the pla- cebo effect on SGRQ to be typically 2 units, with no stud- ies demonstrating increases of >5 units ... See full document
12
<p>Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of the GEM1 and GEM2 12-week studies</p>
... in patients treated with GLY than in those treated with placebo among reversible patients, but not among nonreversible patients (Figure ...reversible patients (Figure ...nonreversible ... See full document
8
Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD
... MF/F 200/10 µg. Serial spirometry results demonstrated that bronchodilator effects with MF/F occurred rapidly (within 5 minutes), persisted for 12 hours after dosing, and were sustained over the 26-week treatment period. ... See full document
9
Comparison of Aerosol Formulations of Formoterol Fumarate and Budesonide
... of metered dose inhalers of salbutamol sulphate and triamcinolone acetonide performed better and gave lower mass median aerodynamic diameter (MMAD) values as compared to their suspension formulation ... See full document
8
Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease
... of patients with COPD. Glycopyrrolate, or glycopyr- ronium bromide, like other LAMAs, inhibits parasympathetic nerve impulses by selectively blocking the binding of acetylcholine to muscarinic ... See full document
38
Systemic Activity of Inhaled Steroids in 1- to 3-Year-Old Children With Asthma
... daily delivered via pressurized metered-dose inhaler (pMDI) and Babyhaler (FP400), was compared with budesonide, 200 g twice daily delivered via pMDI and ... See full document
8
<p>AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD</p>
... in patients with moderate-to-very severe symptomatic COPD compared with monocomponents and TIO at 24 ...score compared with ...sustained efficacy of AB/FF over 24 ... See full document
13
Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD
... randomized patients, 249 completed the study. The primary efficacy variable was the change in forced expiratory volume in one second from predose to 60 minutes after dosing on day ... See full document
74
LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment
... The network meta-analysis was performed using a full Bayesian evidence network (chains: 4; initial values scaling: 2.5; tuning iterations: 20 000; simulation iterations: 50 000; and tuning interval: 10), the convergence ... See full document
15
Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study
... of patients who achieved the MCID in SGRQ total score and TDI focal score was higher with glycopyrrolate versus placebo in this ...status), glycopyrrolate showed significant improvement in the CAT ... See full document
13
Assessment of fine particle fraction of inhaler drug using cascade anderson impactor and hplc
... for inhaler characterization because they provide the required degree of est interest between ...combination metered dose inhaler Formoterol, Tiotropium and Ciclesonide by HPLC as f the ... See full document
6
Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA
... USA. Patients were randomized 7:6:6:3 using an Interactive Web Response System (further details in the Supplementary materials) to receive treatment with GFF MDI ...glycopyrronium/formoterol fumarate ... See full document
17
Long-term safety and efficacy of formoterol fumarate inhalation solution in patients with moderate-to-severe COPD
... investigate severe respiratory- related safety outcomes as a primary end point, the use of an independent MAB, and evaluation of efficacy on top of other maintenance COPD ...for ... See full document
6
Related subjects